The Korea Food and Drug Administration said that a total of 18 incrementally modified drugs (IMDs) were approved over the past three years.
By company, Hanmi Pharmaceutical led any others with five products, followed by MSD Korea with 3 products and others.
Data revealed Friday indicated that the combined output of the 18 IMDs last year posted 101.1 billion won, compared to 65.5 billion w...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.